|
1
|
Buell GN, Talabot F, Gos A, Lorenz J, Lai
E, Morris MA and Antonarakis SE: Gene structure and chromosomal
localization of the human P2X7 receptor. Receptors Channels.
5:347–354. 1998.PubMed/NCBI
|
|
2
|
Sluyter R and Stokes L: Significance of
P2X7 receptor variants to human health and disease. Recent Pat DNA
Gene Seq. 5:41–54. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li X, Qi X, Zhou L, Catera D, Rote NS,
Potashkin J, Abdul-Karim FW and Gorodeski GI: Decreased expression
of P2X7 in endometrial epithelial pre-cancerous and cancer cells.
Gynecol Oncol. 106:233–243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou L, Qi X, Potashkin JA, Abdul-Karim FW
and Gorodeski GI: MicroRNAs miR-186 and miR-150 down-regulate
expression of the pro-apoptotic purinergic P2X7 receptor by
activation of instability sites at the 3′-untranslated region of
the gene that decrease steadystate levels of the transcript. J Biol
Chem. 283:28274–28286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rahman OA, Sasvari-Szekely M, Szekely A,
Faludi G, Guttman A and Nemoda Z: Analysis of a polymorphic
microRNA target site in the purinergic receptor P2RX7 gene.
Electrophoresis. 31:1790–1795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bagga S, Bracht J, Hunter S, Massirer K,
Holtz J, Eachus R and Pasquinelli AE: Regulation by let-7 and lin-4
miRNAs results in target mRNA degradation. Cell. 122:553–563. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lim LP, Lau NC, Garrett-Engele P, et al:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lai EC: Predicting and validating microRNA
targets. Genome Biol. 5:1152004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie X, Lu J, Kulbokas EJ, et al:
Systematic discovery of regulatory motifs in human promoters and 3′
UTRs by comparison of several mammals. Nature. 434:338–345. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Travis WD, Brambilla E, Muller-Hemerlink
HK and Harris CC: World Health Organization Classification of
Tumors. Pathology and Genetics of Tumors of the Lung, Pleura,
Thymus and Heart Lyon, France: IARC Press; 2004
|
|
13
|
Travis WD, Brambilla E, Noguchi M, et al:
International association for the study of lung cancer/American
thoracic society/European respiratory society international
multidisciplinary classification of lung adenocarcinoma. J Thorac
Oncol. 6:244–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Capodanno A, Boldrini L, Alì G,
Pelliccioni S, Mussi A and Fontanini G:
Phosphatidylinositol-3-kinase α catalytic subunit gene somatic
mutations in bronchopulmonary neuroendocrine tumors. Oncol Rep.
28:1559–1566. 2012.PubMed/NCBI
|
|
15
|
Fuller SJ, Stokes L, SkarRatt KK, Gu BJ
and Wiley JS: Genetics of the P2X7 receptor and human disease.
Purinergic Signal. 5:257–262. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brennecke J, Stark A, Russell RB and Cohen
SM: Principles of microRNA-target recognition. PLoS Biol.
3:e852005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mulrane L, McGee SF, Gallagher WM and
O’Connor DP: miRNA dysregulation in breast cancer. Cancer Res.
73:6554–6562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Capodanno A, Boldrini L, Proietti A, et
al: Let-7g and miR-21 expression in non-small cell lung cancer:
correlation with clinicopathological and molecular features. Int J
Oncol. 43:765–774. 2013.PubMed/NCBI
|
|
19
|
Adinolfi E, Raffaghello L, Giuliani AL, et
al: Expression of P2X7 receptor increases in vivo tumor growth.
Cancer Res. 72:2957–2969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
White N and Burnstock G: P2 receptors and
cancer. Trends Pharmacol Sci. 27:211–217. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adinolfi E, Melchiorri L, Falzoni S, et
al: P2X7 receptor expression in evolutive and indolent forms of
chronic B lymphocytic leukemia. Blood. 99:706–708. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chong JH, Zheng GG, Zhu XF, et al:
Abnormal expression of P2X family receptors in Chinese pediatric
acute leukemias. Biochem Biophys Res Commun. 391:498–504. 2010.
View Article : Google Scholar
|
|
23
|
Raffaghello L, Chiozzi P, Falzoni S, Di
Virgilio F and Pistoia V: The P2X7 receptor sustains the growth of
human neuroblastoma cells through a substance P-dependent
mechanism. Cancer Res. 66:907–914. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Solini A, Cuccato S, Ferrari D, et al:
Increased P2X7 receptor expression and function in thyroid
papillary cancer: a new potential marker of the disease?
Endocrinology. 149:389–396. 2008. View Article : Google Scholar
|
|
25
|
Slater M, Danieletto S, Pooley M, Cheng
TL, Gidley-Baird A and Barden JA: Differentiation between cancerous
and normal hyperplastic lobules in breast lesions. Breast Cancer
Res Treat. 83:1–10. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Souza CO, Santoro GF, Figliuolo VR, et al:
Extracellular ATP induces cell death in human intestinal epithelial
cells. Biochim Biophys Acta. 1820:1867–1878. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bian S, Sun X, Bai A, et al: P2X7
integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to
mediate tumor cell death. PLoS One. 8:e601842013. View Article : Google Scholar : PubMed/NCBI
|
